Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Europe

Europe

In Europe, the Digestives & Intestinal Remedies market market generated a revenue of €4.54bn in 2024.
It is projected to experience an annual growth rate of 2.95% (CAGR 2024-2029).
When compared to other countries globally, in China stands out as the highest revenue generator, with €4,087.00m in 2024.
Looking at the per person figures, in 2024, each individual in Europe contributed €5.38 to the revenue of this market.
Germany's Digestives & Intestinal Remedies market is driven by a strong demand for natural and herbal remedies.

Key regions: Canada, United States, Australia, Brazil, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digestives & Intestinal Remedies market in Europe is experiencing significant growth and development.

Customer preferences: Customers in Europe are increasingly seeking natural and herbal remedies for digestive issues. They are becoming more health-conscious and are looking for products that are gentle on their bodies and have minimal side effects. This shift in consumer preferences has led to a rise in demand for natural and herbal digestive remedies in the European market.

Trends in the market: One of the major trends in the Digestives & Intestinal Remedies market in Europe is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are good for digestive health. They help restore the natural balance of bacteria in the gut and improve overall digestion. The demand for probiotic products has been growing rapidly in Europe, as more and more consumers are becoming aware of the benefits of these products. Another trend in the market is the growing demand for over-the-counter (OTC) digestive remedies. OTC products are easily accessible and do not require a prescription. They are preferred by consumers for their convenience and affordability. With the increasing prevalence of digestive issues in Europe, the demand for OTC digestive remedies has been on the rise.

Local special circumstances: In countries like Germany and France, there is a strong tradition of using herbal remedies for various health issues, including digestive problems. This cultural preference for natural remedies has contributed to the growth of the Digestives & Intestinal Remedies market in these countries. Furthermore, the aging population in Europe has also had an impact on the market. As people age, they are more prone to digestive issues and are therefore more likely to seek remedies for these problems. The increasing elderly population in Europe has created a larger customer base for Digestives & Intestinal Remedies, driving market growth.

Underlying macroeconomic factors: The increasing prevalence of digestive issues in Europe can be attributed to several underlying macroeconomic factors. Changes in lifestyle, including unhealthy eating habits and sedentary lifestyles, have contributed to the rise in digestive problems. Additionally, stress and anxiety, which are common in today's fast-paced society, can also negatively impact digestive health. These factors have led to a higher demand for Digestives & Intestinal Remedies in Europe. Moreover, the rising healthcare expenditure in Europe has made it easier for consumers to access and afford digestive remedies. Increased healthcare awareness and government initiatives to promote wellness have also played a role in driving market growth. In conclusion, the Digestives & Intestinal Remedies market in Europe is witnessing significant growth due to changing customer preferences, such as the increasing demand for natural and herbal remedies, as well as the rising popularity of probiotics. Local special circumstances, such as the cultural preference for herbal remedies and the aging population, have also contributed to market development. Underlying macroeconomic factors, including changes in lifestyle and increased healthcare expenditure, are driving the demand for Digestives & Intestinal Remedies in Europe.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.